🇺🇸 FDA
Patent

US 11692018

TGF-β polypeptides

granted A61KA61K38/00A61P

Quick answer

US patent 11692018 (TGF-β polypeptides) held by Cue Biopharma, Inc. expires Mon Jun 29 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Cue Biopharma, Inc.
Grant date
Tue Jul 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 29 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K38/00, A61P, A61P37/00, A61P37/06